Thomas F Holzman

Title: Thomas F Holzman: Innovator in Biotechnology

Introduction

Thomas F Holzman is a notable inventor based in Libertyville, IL (US). He has made significant contributions to the field of biotechnology, particularly in the development of recombinant proteins and their applications in therapeutic and diagnostic settings. With a total of 3 patents, Holzman has demonstrated a commitment to advancing medical science through innovative solutions.

Latest Patents

Holzman's latest patents include groundbreaking work on methods of preparation of recombinant forms of human beta-amyloid protein. This invention focuses on the cloning, expression, and isolation of recombinant forms of beta-amyloid protein, which are crucial for the production of therapeutic antibodies and the identification of small therapeutic molecules. Another significant patent involves the development of stabilized standards and calibrators containing rapamycin. This invention presents an in vitro aqueous composition that enhances the stability of drugs like tacrolimus or rapamycin, utilizing a binding protein to maintain drug integrity in an aqueous matrix.

Career Highlights

Throughout his career, Holzman has worked with prominent companies such as Abbott Laboratories Corporation and Abbott GmbH & Co. KG. His experience in these organizations has allowed him to contribute to various innovative projects and research initiatives.

Collaborations

Holzman has collaborated with esteemed colleagues, including Frank C Grenier and Allan H Smith. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in biotechnology.

Conclusion

Thomas F Holzman is a distinguished inventor whose work in biotechnology has led to significant advancements in therapeutic and diagnostic applications. His innovative patents and collaborations reflect his dedication to improving medical science and patient care.